Pharmaceutical companies are facing accusations of attempting to undermine Australian advertising laws. There are also reports of US lobby groups calling for tariff retaliation against Australia, with some characterizing the country's healthcare system as "socialised medicine". Meanwhile, medical researchers are reportedly urging the government to address a funding crisis, although it is unclear how this relates to the accusations against pharmaceutical companies.